Positions

Overview

  • My major research interest is in multiple myeloma. I, along with my multiple myeloma colleagues, established an interdisciplinary myeloma clinic in March 2013, which is the first clinic of its kind in Alabama dedicated solely to plasma cell malignancies. I have also represented UAB on the NCCN Multiple Myeloma guidelines panel. My future and ongoing goals include opening and expanding clinical trials for the relapsed/refractory multiple myeloma patient population and to continue to serve the growing multiple myeloma patient population.
  • Research Overview

  • Multiple Myeloma, Plasma cell malignancies
  • Principal Investigator On

  • Private Grant  awarded by MILLENNIUM PHARMACEUTICALS, INC. 2013 - 2019
  • Private Grant  awarded by ARRAY BIOPHARMA 2015 - 2016
  • Private Grant  awarded by POLARIS GROUP 2012 - 2015
  • Private Grant  awarded by TGEN DRUG DEVELOPMENT SERVICES 2012 - 2015
  • Private Grant  awarded by INCYTE CORPORATION 2012 - 2013
  • Investigator On

  • UAB 1815: Phase 2 Trial of Intensive Chemo-immu,otherapy with Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Relapsed.Refractory Myeloma In the context of Salvage Autologous Hematopoietic Cell Transplantation  awarded by Memorial Sloan-Kettering Cancer Center 2019 - 2024
  • Private Grant  awarded by REPLIMUNE INC. 2019 - 2024
  • Private Grant  awarded by CELGENE CORPORATION 2019 - 2024
  • Private Grant  awarded by CELGENE CORPORATION 2019 - 2024
  • Private Grant  awarded by AMGEN, INC. 2018 - 2023
  • Private Grant  awarded by GlaxoSmithKline 2018 - 2023
  • Private Grant  awarded by MUNDIPHARMA 2018 - 2023
  • Private Grant  awarded by JUNO THERAPEUTICS 2018 - 2023
  • Private Grant  awarded by IDERA PHARMACEUTICALS, INC. 2018 - 2023
  • Private Grant  awarded by CELGENE INTERNATIONAL II SÀRL 2018 - 2023
  • Private Grant  awarded by AMGEN, INC. 2018 - 2023
  • Private Grant  awarded by Janssen 2018 - 2023
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2017 - 2022
  • Private Grant  awarded by DYNAVAX TECHNOLOGIES CORPORATION 2017 - 2022
  • Private Grant  awarded by F.Hoffmann-La Roche Ltd. 2017 - 2022
  • Private Grant  awarded by F.Hoffmann-La Roche Ltd. 2017 - 2022
  • Private Grant  awarded by DYNAVAX TECHNOLOGIES CORPORATION 2017 - 2022
  • Private Grant  awarded by ABBVIE INC 2016 - 2021
  • Private Grant  awarded by AMGEN, INC. 2016 - 2021
  • Private Grant  awarded by AMGEN, INC. 2016 - 2021
  • Private Grant  awarded by ELIOS THERAPEUTICS 2016 - 2021
  • Private Grant  awarded by SEATTLE GENETICS, INC. 2018 - 2020
  • Private Grant  awarded by KARYOPHARM THERAPEUTICS, INC. 2015 - 2020
  • Alliance for Clinical Trials in Oncology Payment Agreement  awarded by MAYO CLINIC 2017 - 2020
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2016 - 2020
  • Private Grant  awarded by GlaxoSmithKline 2012 - 2020
  • Private Grant  awarded by ELIOS THERAPEUTICS 2015 - 2020
  • Private Grant  awarded by AMGEN, INC. 2015 - 2020
  • Private Grant  awarded by ONYX PHARMACEUTICALS, INC. 2015 - 2020
  • ECOG-ACRIN Purchase Service Agreement  awarded by Eastern Cooperative Oncology Group 2014 - 2020
  • Southwest Oncology Group Purchase Service Agreement  awarded by Oregon Health & Science University 2015 - 2020
  • Private Grant  awarded by CYTRX CORPORATION 2014 - 2019
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2014 - 2019
  • Private Grant  awarded by F.Hoffmann-La Roche Ltd. 2012 - 2019
  • BMT CTN 1302- Multicenter Phase II, Double Blinded, Placebo Controlled Trial of Maintenance Ixazomib after Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Multiple Myeloma  awarded by National Marrow Donor Program 2017 - 2019
  • Prospective Observation of Cardiac Safety with Proteasome Inhibition (PROTECT)  awarded by VANDERBILT UNIVERSITY 2017 - 2019
  • UAB NRG Oncology Member Institution Purchased Service Agreement  awarded by NRG ONCOLOGY FOUNDATION 2015 - 2019
  • UAB NRG Oncology Member Institution Purchased Service Agreement  awarded by NRG ONCOLOGY FOUNDATION 2014 - 2019
  • Private Grant  awarded by TRACON PHARMACEUTICALS, INC. 2013 - 2018
  • Private Grant  awarded by SEATTLE GENETICS, INC. 2013 - 2018
  • Private Grant  awarded by Novartis Pharma AG 2013 - 2018
  • Private Grant  awarded by Novartis Pharma AG 2014 - 2018
  • Private Grant  awarded by Genentech 2011 - 2017
  • Private Grant  awarded by BOSTON SCIENTIFIC CORPORATION 2016 - 2017
  • Private Grant  awarded by MERCK & COMPANY, INC. 2013 - 2017
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2014 - 2017
  • Private Grant  awarded by NEWLINK GENETICS, INC 2016 - 2017
  • Private Grant  awarded by EMD SERONO 2012 - 2016
  • Private Grant  awarded by F.Hoffmann-La Roche Ltd. 2013 - 2016
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2011 - 2016
  • Private Grant  awarded by Genentech 2012 - 2015
  • Private Grant  awarded by MERRIMACK PHARMACEUTICALS, INC. 2013 - 2015
  • Private Grant  awarded by Genentech 2011 - 2015
  • Education And Training

  • UAB Hospital, Internship 2006
  • UAB Hospital, Residency 2008
  • Full Name

  • Kelly Godby